ASG. Aurora Spine Corp

Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference

Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference

CARLSBAD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the Lytham Partners Fall 2022 Investor Conference, taking place virtually on September 28-29, 2022. During the event, the company will be participating in a webcasted presentation discussion and conducting 1x1 virtual investor meetings.

The Company’s webcast presentation will be a Panel Discussion hosted by Trent Northcutt, President and CEO and Krissy Ramey, National Director of Clinical Education of Aurora Spine. The discussion is titled: Simplifying the Complex – A Panel Discussion with Doctors that use Aurora Products, and will be available for viewing at 9:00am ET on Wednesday, September 28, 2022, at or on the Company's website. The webcast will also be archived and available for replay.

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at or register at .

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at -spine.com or

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Chad Clouse

Chief Financial Officer

(760) 424-2004

Adam Lowensteiner

Lytham Partners, LLC

Phoenix | New York

Telephone: 646-829-9700



EN
20/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aurora Spine Corp

 PRESS RELEASE

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody...

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device CARLSBAD, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces the official launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device, with the product being implanted in recent initial surgeries. DEXA-L is part of Aurora’s patented DEXA™ Technology Platform, which is a series of products that are the world’s first bone density ...

 PRESS RELEASE

Aurora Spine Corporation Announces Record Second Quarter Financial Re...

Aurora Spine Corporation Announces Record Second Quarter Financial Results  - Company to host conference call Tuesday, September 2nd at 11am ET/8am PT -  NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for second quarter ended June 30, 2025. All figures are in U.S. dollars. Significant ...

 PRESS RELEASE

Aurora Spine Announces Participation in 7th Annual American Society of...

Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference CARLSBAD, California, July 15, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced it will be participating in the 7th Annual ASPN Conference sponsored by The American Society of Pain Neuroscience (ASPN) to be held July 17-20 at the Fontainebleu Miami Hotel in Miami Beach, Florida. Aurora will be located at Booth 129/130.To kick off the fir...

 PRESS RELEASE

Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion...

Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System CARLSBAD, CALIFORNIA, July 09, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced initial surgeries using Aurora Spine’s newest product, the AERO™ Lumbar Fusion System, have commenced. The minimally invasive procedures using the AERO were conducted by two different surgeons, one ortho surgeon and one interventionalist. The initial surgeries performed were procedu...

 PRESS RELEASE

Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™

Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™ Award-Winning DEXA Technology™ Continues to Redefine Patient-Matched Spinal Care CARLSBAD, CALIFORNIA, June 16, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spinal implant technology, is proud to announce that its DEXA-C™ system has now been successfully used in more than 1,500 cervical spine procedures across the United States. This milestone underscores the ongoing adoption and trusted performance of the DEXA Technology™ platfo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch